Lung endothelia in the arteries, capillaries, and veins are heterogeneous in structure and function. Lung capillaries in particular represent a unique vascular niche, with a thin yet highly restrictive alveolar-capillary barrier that optimizes gas exchange. Capillary endothelium surveys the blood while simultaneously interpreting cues initiated within the alveolus and communicated via immediately adjacent type I and type II epithelial cells, fibroblasts, and pericytes. This cell-cell communication is necessary to coordinate the immune response to lower respiratory tract infection. Recent discoveries identify an important role for the microtubule-associated protein tau that is expressed in lung capillary endothelia in the host-pathogen interaction. This endothelial tau stabilizes microtubules necessary for barrier integrity, yet infection drives production of cytotoxic tau variants that are released into the airways and circulation, where they contribute to end-organ dysfunction. Similarly, beta-amyloid is produced during infection. Beta-amyloid has antimicrobial activity, but during infection it can acquire cytotoxic activity that is deleterious to the host. The production and function of these cytotoxic tau and amyloid variants are the subject of this review. Lung-derived cytotoxic tau and amyloid variants are a recently discovered mechanism of end-organ dysfunction, including neurocognitive dysfunction, during and in the aftermath of infection.
Many patients suffer from incident dementia after lung infections. Previous studies demonstrated that cytotoxic tau is released from the lungs in response to bacterial pneumonia, causing cognitive deficits and tau seeding. We aimed to determine the impact pneumonia has on blood-brain barrier (BBB) permeability, glial activation, and tau phosphorylation in the brain following infection and the involvement of tau. We found that lung infection with Pseudomonas aeruginosa (P. aeruginosa) increased BBB permeability, astrocyte activation, and phosphorylated tau (ptau) levels in the brain 24-hours (h) post-infection in C57BL/6J mice. Conversely, tau knockout (KO) mice had no BBB injury or glial activation 24 h after infection. Additionally, we found increased levels of several kinases and proinflammatory cytokines with infection in C57BL/6J and tau KO mice. Thus, tau is necessary for pneumonia-induced BBB dysfunction and astrocyte reactivity in the brain and may be an innate immune response link between infection and dementia.
10 March 2026 in American Journal of Respiratory Cell and Molecular Biology
Cytopathic tau variants are recovered from the lung, circulation, and brain following lower respiratory tract infection. Cytopathic tau injures the lung and brain, yet its cellular origin during infection is unknown. Here, we assessed whether lung capillary endothelium is a source of cytopathic tau that contributes to brain injury during infection. Alveolar-capillary permeability was higher in tau knockout than wild type mice following sublethal Pseudomonas aeruginosa infection, indicating endogenously expressed tau contributes to integrity of the lung’s gas exchange unit. Hippocampal long-term potentiation was inhibited following sublethal infection in wild type but not tau knockout mice, even though the blood-brain barrier was not overtly disrupted. Tau expression solely in lung capillaries of tau knockout mice was sufficient to restore alveolar-capillary barrier integrity and impair hippocampal long-term potentiation following sublethal infection. Thus, endogenous lung capillary endothelial tau preserves alveolar-capillary integrity, yet it is a source of cytopathic tau that injures the brain during pneumonia.
1 September 2026 in American Journal of Physiology-Heart and Circulatory Physiology
Age- and disease-related declines in brain health contribute to impairments in physical function, yet effective approaches to lessen these declines remain limited. Overall health is governed by a network of interdependent organ systems, such that dysfunction in one system can propagate across others. Although the brain has been viewed as a top-down regulator of vital functions, evidence indicates that cognition is affected by signals from peripheral organs. This interorgan communication likely explains the coexistence of Alzheimer’s disease and related dementias with cardiovascular and metabolic disorders characterized by overlapping pathophysiology. Skeletal muscle and the peripheral vasculature are key contributors to this and represent modifiable systems that can alter brain structure and function. Skeletal muscle regulates myokine release through motor neuron function, contractile activity, and metabolic perturbations, thereby influencing neuroplasticity, mitochondrial function, and inflammatory signaling, and may affect measures of peripheral vascular function, like reactive hyperemia. Other properties of the vasculature, including arterial stiffness, directly affect cerebral perfusion and blood-brain barrier permeability. These systems form a muscle-vascular-brain axis that contributes to brain health and impacts the risk of cognitive impairment. Therefore, our aim was to synthesize the current understanding of interactions among skeletal muscle, the peripheral vasculature, and the brain, and their collective role in maintaining cognitive health. We also highlight recent clinical trials and emerging strategies affecting interorgan cross talk. These conclusions support a model in which lifestyle interventions targeting peripheral systems, such as resistance training, may preserve brain health across all populations, offering scalable approaches applicable across the lifespan.